Article Text

PDF
SP0042 Raynaud’s Phenomenon: A Clinical Symptom that Must be Diagnosed by Capillaroscopy
  1. A. Herrick1
  1. 1University of Manchester, Salford, United Kingdom

Abstract

Nailfold capillaroscopy plays a key role in the assesssment of the patient with Raynaud’s phenomenon, in that it allows early identification of the patient with an underlying systemic sclerosis (SSc)-spectrum disorder [1,2]. This session will review the criteria for primary (idiopathic) Raynaud’s phenomenon, outline the rationale for separating this out from secondary Raynaud’s phenomenon (with a focus on SSc-related Raynaud’s phenomenon) [3], discuss capillaroscopic abnormalities as a predictor of SSc [4,5], and discuss the recently proposed criteria for very early SSc [6,7] (highlighting capillaroscopy).

Upon completion of the session, participants should be able to:

  1. Discuss the role of capillaroscopy in the assessment of the patient presenting with Raynaud’s phenomenon.

  2. Describe the rationale for very early diagnosis of SSc.

  1. Herrick, A.L. & Cutolo, M. Clinical implications from capillaroscopic analysis in patients with Raynaud’s phenomenon and systemic sclerosis. Arthritis Rheum. 62, 2595-2604 (2010).

  2. Cutolo, M., Sulli, A. & Smith, V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat. Rev. Rheumatol. 6, 578-587 (2010).

  3. Herrick, A.L. The pathogenesis, diagnosis and treatment of primary and secondary Raynaud’s phenomenon. Nat. Rev. Rheumatol. 8, 469-79 (2012).

  4. Koenig, M, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 58, 3902-3912 (2008).

  5. Ingegnoli, F. et al. Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatol. 49, 797-805 (2010).

  6. Matucci-Cerinic, M. et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research Group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann. Rheum. Dis. 68, 1377-1380 (2009).

  7. Avouac, J. et al Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann. Rheum. Dis. 70, 476-481 (2011).

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.